Observational Study of Vectibix With Chemotherapy for Metastatic Colorectal Cancer Patients

Participants receiving panitumumab in combination with chemotherapy as prescribed by the treating physician prior to enrollment in this study and according to routine clinical practice for patients with wild-type RAS metastatic colorectal cancer.